Search Beyond News…

American Lung Association launches campaign to educate providers on COVID-19 treatment options

Executive summary: On July 28, 2026, the American Lung Association announced a campaign to educate healthcare providers about available therapeutic options for preventing and treating COVID-19, targeting high‑risk populations. Increasing provider awareness of authorized COVID‑19 therapies can improve treatment uptake, potentially lowering severe illness rates and reducing strain on healthcare systems.

Who is involved: American Lung Association, U.S. healthcare providers, and patients at high risk for severe COVID‑19.

Likely next: The association plans to roll out educational webinars and materials through August‑September 2026, with follow‑up assessment of prescribing trends.

On July 28, 2026 the American Lung Association issued a press release announcing a nationwide campaign to inform healthcare providers about the therapeutic options currently available to prevent and treat COVID‑19. The initiative focuses on high‑risk patients and aims to improve lung health through targeted education. By raising provider awareness, the association hopes to increase appropriate use of authorized treatments and reduce severe outcomes.

Timeline

Sources

Related cases

Browse the full archive →